Biotechnology

Lundbeck to establish global innovation hub in Greater Boston and relocate US headquarters

* The new hub in Greater Boston will bring Lundbeck closer to one of the world's leading life sciences ecosystems, strengthening access to science, talent and partnerships. * The move is part of Lundbeck's continued investment in the US, a key market, and will support the company's Focused In...

2026-09-25 15:52 1456

Gene Solutions Study Finds Preterm-Birth Signals in Routine triSure NIPT Data

A Gene Solutions study published in American Journal of Obstetrics & Gynecology (AJOG) Global Reports finds cell-free DNA fragmentomic patterns associated with spontaneous preterm birth, pointing to a potential path toward earlier pregnancy-risk assessment. SINGAPORE, Sept. 25, 2026 /PRNewswire/...

2026-09-25 13:10 1244

Basecamp Research raises $140M to advance AI-designed therapeutics

/C O R R E C T I O N -- Basecamp Research/ In the news release, Basecamp Research raises $140M to advance AI-designed therapeutics, issued 23-Sep-2026 by Basecamp Research over PR Newswire, we are advised by the company that information has changed in the first bulleted subheadline and in the fo...

2026-09-25 01:44 1481

Windsor Capital Completes $50 Million Strategic Investment in Space Labs

Investment for a 4.9% minority stake implies an approximately $1 billion post-money valuation for the Slovenian technology company. HONG KONG and LJUBLJANA, Slovenia, Sept. 24, 2026 /PRNewswire/ -- Windsor Capital today announced the completion of a $50 million strategic investment in Space Labs...

2026-09-24 21:09 1798

Daewoong Pharmaceutical Presents Baseline Characteristics of 104 Patients in Global Phase 2 Trial for IPF Drug Candidate 'Bersiporocin' at ERS 2026

* 104 IPF patients enrolled in US and South Korea as global Phase 2 trial progresses toward completion * Study includes both antifibrotic-treated and untreated patients; top-line data expected in H1 2027 * First-in-class PRS inhibitor being developed as a potential new therapeutic option...

2026-09-24 08:00 1841

Werfen Announces US FDA 510(k) Clearance and CE Mark for Aptiva® Antiphospholipid Syndrome IgA Reagent

FDA Clearance and CE Mark Complete Aptiva's Antiphospholipid Syndrome Portfolio, Expanding Global Access to Comprehensive APS Testing SAN DIEGO, Sept. 23, 2026 /PRNewswire/ -- Werfen today announced that its Aptiva Antiphospholipid Syndrome (APS) Immunoglobulin A (IgA) Reagent has received both ...

2026-09-23 20:00 1044

Angel Yeast's Angeopro™ Yeast Protein Achieves Dual International Certifications

Setting a New Standard in High-Quality Nutrition SHANGHAI, Sept. 23, 2026 /PRNewswire/ -- Angeopro™ Yeast Protein range F80, F84, Hi90-A, and S80-A, developed byAngel Yeast (SSE: 600298), recently receivedMonash University Low FODMAP CertifiedTM

2026-09-23 19:13 1376

HKSH Medical Group and United Imaging Mark Launch of Hong Kong's First Long-Axial PET/CT

HONG KONG, Sept. 23, 2026 /PRNewswire/ -- HKSH Medical Group (HKSH) and United Imaging Healthcare (United Imaging) announced on September 23 the arrival of Hong Kong's first long-axial PET/CT, the uMI Panorama GS, at HKSH Cancer Centre, providing a new technology platform for molecular imaging cl...

2026-09-23 18:30 751

Novo receives Singapore approval for Wegovy® as first treatment for MASH with liver fibrosis

ESSENCE trial data showed 63% of participants receiving semaglutide achieved steatohepatitis resolution without worsening of liver fibrosis, compared with 34% receiving placebo, at Week 72. * Singapore's Health Sciences Authority (HSA) has approved Wegovy® (once-weekly injectable semaglutide 2...

2026-09-23 10:05 2018

Mayo Clinic Laboratories Invests in Pathology Asia Holdings and LifeStrands Genomics to Advance Diagnostics and Precision Medicine

SINGAPORE, Sept. 23, 2026 /PRNewswire/ -- Mayo Clinic Laboratories  and Pathology Asia Holdings  (PAH) have announced a strategic investment and collaboration aimed at expanding access to advanced diagnostics and precisio...

2026-09-23 09:30 533

Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration

* New flagship facility provides hands-on access to Bio-Techne technologies, workflows and scientific expertise * Regional hub will support researchers and organizations across the DACH and broader EMEA regions * Center strengthens collaboration, training and innovation within Europe's life...

2026-09-22 21:00 1712

Angel Yeast Explores a New Approach to Salt Reduction Without Compromising Flavor

BEIJING, Sept. 22, 2026 /PRNewswire/ -- At the 2026 Food Science Salt Reduction Technology Symposium held recently in Beijing,Angel Yeast (SSE: 600298) joined more than 200 experts and representatives from academia and industry to discuss salt-reduction technologies, ...

2026-09-22 20:54 724

Kazia Therapeutics Announces Sovargen Co. Doses First Patient in Phase 1b/2a Trial of Paxalisib for Rare Seizure Disorders

Clinical Milestone Expands Development of Paxalisib Beyond Oncology and Triggers $2 Million Payment to Kazia SYDNEY, Sept. 22, 2026 /PRNewswire/ -- Kazia Therapeutics Limited

2026-09-22 19:30 1517

Multiple Sacituzumab Tirumotecan (sac-TMT) Studies Selected as LBAs at ESMO 2026, OptiTROP-Lung04 and OptiTROP-Lung06 to be Presented in the Lung Cancer Session

CHENGDU, China, Sept. 22, 2026 /PRNewswire/ -- The 2026 European Society for Medical Oncology (ESMO) Congress will be held in Madrid, Spain, from October 23 to 27. Multiple Phase III clinical studies of the TROP2 ADC sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) (佳泰莱®) developed...

2026-09-22 15:48 1149

Clean Bio Korea to Showcase Indonesia-Validated Air-Fit at Hospital Expo 2026

SEOUL, South Korea, Sept. 21, 2026 /PRNewswire/ -- Clean Bio Co., Ltd, a Korean indoor air quality solutions company, will showcase Air-Fit, its air purification, sterilization and deodorization solution, at Indonesia Int'l Hospital Expo 2026, taking place October 7–10, 2026.

2026-09-21 11:00 1488

Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse

* Transformational merger reinforces Telix's long-term growth strategy as a vertically integrated radiopharmaceutical company with enhanced capabilities across development, isotope production and global manufacturing, underpinned by commercial excellence and the industry's most extensive therap...

2026-09-21 09:59 1662

Antengene Announces First Patient Dosed in Pivotal Phase III CLINCH-3 Study of ATG-022

SHANGHAI and HONG KONG, Sept. 21, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune di...

2026-09-21 08:30 1225

S2S China Announces 2026 Finalists, Ten Standout Teams Set to Pitch Global Investors at Westlake University

SHANGHAI, Sept. 20, 2026 /PRNewswire/ -- The inaugural S2S China Symposium has announced the finalists of its 2026 program. Co-hosted by RA Capital Management and Qiming Venture Partners, S2S China is the China chapter of Science2Startup, an invitation-only symposium connecting top academic resea...

2026-09-20 20:24 2480

BioShanghai Week 2026 Opens -- Joining Forces to Build a Global Biopharmaceutical Innovation Ecosystem

SHANGHAI, Sept. 20, 2026 /PRNewswire/ -- A news report from Yicai Global: On September 17, the BioShanghai Week 2026 opened at Zhangjiang Science Hall in Shanghai. Themed "AI for Biopharma, Health ...

2026-09-20 13:11 1946

Fosun Health Hosts First International Oncology Treatment Forum in Foshan; International Oncology Alliance Officially Established

FOSHAN, China, Sept. 20, 2026 /PRNewswire/ -- The first International Oncology Treatment Forum, hosted by Fosun Health, was held in Foshan, Guangdong Province, China. Oncology experts from multiple countries and regions participated in the exchanges, discussing the development of international r...

2026-09-20 09:00 2098
12345 ... 185

Week's Top Stories